Medium materiality6/10
Procept BioRobotics downgraded to Hold from Buy at Truist
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist Financial downgrades PRCT to Hold; posted price $21.03 with a target of $25, indicating limited upside and a cautious stance.
- Downgrade to Hold signals cautious/negative stance; upside may be limited.
Key facts
- 01
Target: $25
- 02
Posted price: $21.03
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.